Yazan Migdady, MD, MSc
Yazan Migdady, MD is a quadruple board-certified, fellowship-trained hematologist/oncologist with special interest in the treatment of leukemia and hematological malignancies, especially allogenic (donor) bone marrow transplant and novel cellular therapy treatment.
Dr. Migdady graduated with honors from the Jordan University of Science and Technology. He then relocated to Houston, TX where he attended Baylor College of Medicine as a post-doctoral associate at the Lester & Sue Smith Breast Center. Dr. Migdady then went to Alpert Medical School of Brown University in Rhode Island where he completed an internal medicine residency program. He furthered his studies with a Master of Science in medical sciences (MSc) at the University of Florida in Gainsville, FL. From there, he completed a transfusion medicine fellowship at Stanford in Palo Alto, CA and then a hematology and oncology fellowship at the National Institutes of Health in Bethesda, MD (National Cancer Institute (NCI)/National Health, Lung and Blood Institute (NHLBI))
Dr. Migdady is committed to both continued excellence in clinical practice and ongoing innovation through research. He is specifically interested in optimizing transplant therapies, increasing access to novel therapies and advancing the field of medicine.
Financial relationships
-
Attribution:SelfNature of financial relationship:OtherIneligible company:Servier Pharmaceuticals LLCTopic:AML advisory boardsDate added:10/15/2024Date updated:10/15/2024Relationship end date:09/18/2024
-
Attribution:SelfNature of financial relationship:OtherIneligible company:Medexus pharmaceuticalsTopic:Treosulfan advisory boardsDate added:10/15/2024Date updated:10/15/2024Relationship end date:09/19/2024
-
Attribution:SelfNature of financial relationship:OtherIneligible company:Rigel PharmaceuticalsTopic:AML advisory boardsDate added:10/15/2024Date updated:10/15/2024Relationship end date:09/22/2024